Selection and characterization of a human neutralizing antibody to human fibroblast growth factor-2

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 767-773

  Tao, Jun ^b   Xiang, Jun Jian ^a,b   Li, Dan ^b   Deng, Ning ^a   Wang, Hong ^a   Gong, Yi Ping ^a  

^a JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

FGF 2; Human antibody; Neutralizing; Phage display; Single chain Fv; Tumor therapy

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 2 ANTIBODY; IMMUNOGLOBULIN G1; NEUTRALIZING ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL STRAIN HEK293; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOMA CELL; HUMAN; HUMAN CELL; MIGRATION INHIBITION; MITOSIS INHIBITION; PHAGE DISPLAY; PRIORITY JOURNAL; UMBILICAL VEIN;

ANTIBODIES, NEUTRALIZING; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; NEOPLASMS;

EID: 77950518074     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.067     Document Type: Article

References (16)

1. Jenkins J.K., Suwannaroj S., Elbourne K.B., Ndebele K., and McMurray R.W. 17-β-estradiol alter Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin, A. Int. Immunopharmacol. 1 (2001) 1897-1911
2. Barclay C., Li A.W., Geldenhuys L., Baguma-Nibasheka M., Porter G.A., Veugelers P.J., Murphy P.R., and Casson A.G. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin. Cancer Res. 11 (2005) 7683-7691
3. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., and Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16 (2005) 159-178
4. Bikfalvi A., Klein S., Pintucci G., and Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18 (1997) 26-45
5. Ribatti D., Vacca A., Rusnati M., and Presta M. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 18 (2007) 327-334
6. Hicklin D.J., Witte L., Zhu Z., Liao F., Wu Y., Li Y., and Bohlen P. Monoclonal antibody strategies to block angiogenesis. Drug Discov. Today 6 (2001) 517-528
7. Hu D.E., Hori Y., Presta M., Gresham G.A., and Fan T.P. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 18 (1994) 45-58
8. Reilly T.M., Taylor D.S., Herblin W.F., Thoolen M.J., Chiu A.T., Watson D.W., and Timmermans P.B. MAb directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem. Biophys. Res. Commun. 164 (1989) 736-743
9. Coppola G., Atlas-White M., Katsahambas S., Bertolini J., Hearn M.T., and Underwood J.R. Effect of intraperitoneally, intravenously and intralesionally administered monoclonal anti-beta-FGF antibodies on rat chondrosarcoma tumor vascularization and growth. Anticancer Res. 17 (1997) 2033-2039
10. Satoh H., Shino A., Sato F., Asano S., Murakami I., Inatomi N., Nagaya H., Kato K., Szabo S., and Folkman J. Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats. Jpn. J. Pharmacol. 73 (1997) 59-71
11. Hori A., Sasada R., Matsutani E., Naito K., Sakura Y., Fujita T., and Kozai Y. Suppression of solid tumor growth by immunoneutralizing mAb against human basic fibroblast growth factor. Cancer Res. 51 (1991) 6180-6184
12. Nemati M.N., Stan A.C., Pütz K.M., Pietsch T., Walter G.F., and Dietz H. Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against basic fibroblast growth factor. Zentralbl. Neurochir. 57 (1996) 12-19
13. Qiao Y.Y., Wang Y., Chen X., and Hua B. Construction of a large single-chain phage antibody library. Chin. J. Microbiol. Immunol. 24 (2004) 194-197
14. Goletz S., Christensen P.A., Kristensen P., Blohm D., Tomlinson I., Winter G., and Karsten U. Selection of large diversities of antiidiotypic antibody fragments by phage display. J. Mol. Biol. 315 (2002) 1087-1097
15. Giavazzi R., Sennino B., Coltrini D., Garofalo A., Dossi R., Ronca R., Tosatti M.P., and Presta M. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am. J. Pathol. 162 (2003) 1913-1926
16. Dunn I.F., Heese O., and Black P.M. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J. Neurooncol. 50 (2000) 121-137